1-1 of 1
Andrea Lombardi Borgia
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I/II Study of NMS-03592088, a FLT3, KIT and CSF1R Inhibitor, in Patients with Relapsed or Refractory AML or CMML

Marina Ciomei, Lucia Zanetta, Federico Lussana, MD, Erika Ravelli, MD, Francesco Fiorentini, Roberta Bosotti, Elena Ardini, Andrea Lombardi Borgia, Romana Pulci, Rosalinda Gatto, Alessandro Di Sanzo, Elena Colajori, MD, Cristina Davite, Arturo Galvani, Frank Xiaodong Gan, Giuseppe Rossi, Matteo Giovanni Della Porta, MD, Roberto Cairoli, MD, Alessandro Rambaldi, MD, Antonella Isacchi
Journal: Blood
Blood (2019) 134 (Supplement_1): 3855.
https://doi.org/10.1182/blood-2019-121954
Published: 2019